DeviceClearance

ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISA— 510(k) K163177

Substantially Equivalent

Immco Diagnostics, Inc.

FDA 510(k) clearance K163177 for ImmuLisa Enhanced Gliadin IgA Antibody ELISA, ImmuLisa Enhanced Gliadin IgG Antibody ELISA, Substantially Equivalent on 2017-07-28. Applicant: Immco Diagnostics, Inc..

Clearance details

Applicant
Immco Diagnostics, Inc.
Product code
Code MST
Advisory panel
Immunology
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Clarence, NY, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.